Inositol hexakisphosphate kinase 2 sensitizes ovarian carcinoma cells to multiple cancer therapeutics.

Morrison, Bei H

Inositol hexakisphosphate kinase 2 sensitizes ovarian carcinoma cells to multiple cancer therapeutics. [electronic resource] - Oncogene Mar 2002 - 1882-9 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

0950-9232

10.1038/sj.onc.1205265 doi


Antineoplastic Agents--therapeutic use
Apoptosis--drug effects
Caspase 8
Caspase 9
Caspases--genetics
Female
Gamma Rays
Gene Expression Regulation, Enzymologic
Humans
Interferon-beta--pharmacology
Ovarian Neoplasms--drug therapy
Phosphotransferases (Phosphate Group Acceptor)--physiology
Proto-Oncogene Proteins c-bcl-2--physiology
RNA, Messenger--metabolism
Radiation-Sensitizing Agents
Receptors, TNF-Related Apoptosis-Inducing Ligand
Receptors, Tumor Necrosis Factor--genetics
Ribonucleases--genetics
Transfection
Tumor Cells, Cultured--drug effects
Tumor Stem Cell Assay